IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Hospitals and facilities in Rhode Island

In 2025 Q1–Q4, the provider or facility offer prevailed in 91.0% of 2,589 determined Federal IDR dispute line items for hospitals and facilities in Rhode Island. The median prevailing offer was 3.02x the QPA (25th–75th percentile 1.58x–5.10x; n = 1,447). The median time to a decision was 40 business days (n = 2,589).

Determined line items

2,589

2025 Q1–Q4 · 4 split decisions excluded

Provider win rate

91.0%

n = 2,589 · 2025 Q1–Q4

Median payment vs QPA

3.02x

middle half 1.58x–5.10x · n = 1,447 · 2025 Q1–Q4

Median days to decision

40

business days, from dispute initiation · n = 2,589 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q42,58991.0%3.02x1.58x–5.10x1,44740
2024 Q1–Q41,15799.9%4.05x1.97x–5.56x63131
2023 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–2025 Q43,75393.6%3.11x1.64x–5.23x2,085not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
85025 Complete blood cell count (red cells, white blood cell, platelets), automated te14787.1%5.12x11340
36415 Insertion of needle into vein for collection of blood sample12191.7%–1640
99285 Emergency department visit with high level of medical decision making10093.0%1.96x6144.5
80053 Blood test, comprehensive group of blood chemicals9289.1%9.65x7542
84484 Troponin (protein) analysis, quantitative8184.0%4.28x6041
83690 Lipase (fat enzyme) level7788.3%4.05x6442
96361 Infusion into a vein for hydration, each additional hour6995.7%1.00x4736
96374 Injection of drug or substance into vein6994.2%–2237
93005 Routine electrocardiogram (ECG) using at least 12 leads with tracing6693.9%2.86x5342.5
99284 Emergency department visit with moderate level of medical decision making6493.8%2.51x3938
96375 Injection of additional new drug or substance into vein5996.6%–2240
80048 Blood test, basic group of blood chemicals (Calcium, total)5585.5%6.84x4439
71046 X-ray of chest, 2 views4192.7%2.45x3339
81025 Urine pregnancy test3789.2%5.58x3235
83735 Magnesium level3786.5%–2640
74177 CT scan of abdomen and pelvis with contrast36100.0%–2844
81001 Manual urinalysis test with examination using microscope, automated3387.9%–2440
81003 Automated urinalysis test3390.9%–2038

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Rhode Island · Hospitals and facilities in all states

FAQ

What is the Federal IDR provider win rate for hospitals and facilities in Rhode Island?

In 2025 Q1–Q4, the provider or facility offer was selected in 91.0% of 2,589 determined dispute line items for hospitals and facilities in Rhode Island. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for hospitals and facilities in Rhode Island?

In 2025 Q1–Q4, the median prevailing offer was 3.02x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 1.58x to 5.10x (n = 1,447 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for hospitals and facilities in Rhode Island?

In 2025 Q1–Q4, the median was 40 business days (n = 2,589 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR